Intestinal Toxicity Assessment with Patient-Derived Organoids
liamisc2023-03-27T15:38:56-04:00Cell & Molecular Biology, Drug Discovery & Development, Pharmacology, Toxicology|
Dr. Martin Stahl describes the use of patient-derived intestinal organoids to assess the toxicity of potential therapeutic compounds and study barrier function in a human-specific model system.
Featured Webinars
Cut and Paste of Myosin Binding Protein-C in Striated Muscles
Tuesday, October 3, 2023
Sponsor: Aurora Scientific, Inc.
Partner: American Physiological Society
Evaluation of Novel Therapies Using Spontaneous Seizure Models
Wednesday, October 4, 2023
Sponsor: ADInstruments
Partners: American Physiological Society, Society for Neuroscience, Federation of European Neuroscience Societies, American Autonomic Society, Scientist.com
Revolutionizing Immunotherapy Research with 3D, Multiplexed Cryo-fluorescence Tomography
Thursday, October 5, 2023
Sponsor: EMIT Imaging
Partner: Scientist.com
Advertisement
Latest News & Resources
The Sweet Truth: Unwrapping the Science of Semaglutide
August 9, 2023
Taurine: An Unexpected Anti-Aging Ally
July 18, 2023
Content Categories
Aging
Analytical Sciences
Animal Behavioral Neuroscience
Auditory Sciences
Cancer & Oncology Research
Cardiovascular
Cell & Molecular Biology
Clinical Research
Drug Discovery & Development
Education & Teaching
Epidemiology & Infectious Disease
General Biology
Genetics & Genomics
Human Physiology
Industry & Career
Lab Animal Sciences
Materials Science
Metabolic Function
Microbiology & Immunology
Microscopy
Muscle Physiology & Function
Neuroscience
Obesity
Pharmacology
Preclinical Imaging
Renal Physiology
Respiratory Science
Sports Science
Toxicology
Value, Evidence, Access
Vascular Biology
Vision Research